Consistent with previous studies [49–51], the present study identified increases in the expression of the general inflammation marker MMP12 and the Th17 marker CCL20 in AD skin lesions, whereas ADSC treatment reversed these changes. Here, MMP12 is linked to Alzheimer disease.